Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR+8.6%
5Y CAGR-4.2%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+8.6%/yr
vs -35.7%/yr prior
5Y CAGR
-4.2%/yr
Recent acceleration
Acceleration
+44.3pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 12.69% |
| 2024 | 39.56% |
| 2023 | 20.03% |
| 2022 | 9.92% |
| 2021 | 3.56% |
| 2020 | 15.72% |
| 2019 | 22.33% |
| 2018 | 58.07% |
| 2017 | 96.37% |
| 2016 | 62.01% |